tenk.fyi

ACHIEVE LIFE SCIENCES, INC.

ACHVNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

-

Net Income

-$39.8M

33.6% YoY

EPS

$-1.24

17.3% YoY

Cash

$12.8M

18.0% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro